General MedicationsINJECTIONGeneric
DOXERCALCIFEROL
DOXERCALCIFEROL
Standard Dose
2MCG/ML (2MCG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DOXERCALCIFEROL is listed in Drugs@FDA under application 213717 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXERCALCIFEROL Form and strength INJECTABLE;INJECTION - 2MCG/ML (2MCG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-01-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOXERCALCIFEROL is listed in Drugs@FDA under application 213717 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXERCALCIFEROL Form and strength INJECTABLE;INJECTION - 2MCG/ML (2MCG/ML) Sponsor EUGIA PHARMA Submission history Latest submission status date: 2022-01-24 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.